Opting for generic over brand name prescription drugs would save millions a year

A new study by Johns Hopkins Bloomberg School of Public Health found the Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by doctors had been substituted by a generic option. The study also found that in 2017 under this program, prescribing clinicians and patients together requested brand name drugs over generics 30 percent of the time when a brand name drug was dispensed. Of the 169 million filled prescriptions, the study found 8.5 million involved prescribing providers requesting a brand-name drug over a generic version and another 13.5 percent of patients requesting brand-name drugs versus generic options. Read the article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org